Evergreen Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $554K | Buy |
6,686
+1,625
| +32% | +$135K | 0.02% | 517 |
|
2025
Q1 | $410K | Hold |
5,061
| – | – | 0.01% | 586 |
|
2024
Q4 | $456K | Hold |
5,061
| – | – | 0.01% | 544 |
|
2024
Q3 | $500K | Hold |
5,061
| – | – | 0.02% | 496 |
|
2024
Q2 | $469K | Hold |
5,061
| – | – | 0.02% | 485 |
|
2024
Q1 | $480K | Buy |
5,061
+61
| +1% | +$5.79K | 0.02% | 460 |
|
2023
Q4 | $446K | Hold |
5,000
| – | – | 0.02% | 450 |
|
2023
Q3 | $365K | Hold |
5,000
| – | – | 0.02% | 489 |
|
2023
Q2 | $416K | Hold |
5,000
| – | – | 0.02% | 439 |
|
2023
Q1 | $381K | Sell |
5,000
-50
| -1% | -$3.81K | 0.02% | 439 |
|
2022
Q4 | $419K | Hold |
5,050
| – | – | 0.02% | 404 |
|
2022
Q3 | $401K | Hold |
5,050
| – | – | 0.02% | 386 |
|
2022
Q2 | $375K | Sell |
5,050
-11
| -0.2% | -$817 | 0.02% | 378 |
|
2022
Q1 | $455K | Hold |
5,061
| – | – | 0.02% | 394 |
|
2021
Q4 | $567K | Hold |
5,061
| – | – | 0.02% | 356 |
|
2021
Q3 | $636K | Hold |
5,061
| – | – | 0.03% | 327 |
|
2021
Q2 | $685K | Hold |
5,061
| – | – | 0.03% | 301 |
|
2021
Q1 | $687K | Hold |
5,061
| – | – | 0.04% | 290 |
|
2020
Q4 | $712K | Sell |
5,061
-5,900
| -54% | -$830K | 0.04% | 253 |
|
2020
Q3 | $1.22M | Hold |
10,961
| – | – | 0.08% | 186 |
|
2020
Q2 | $1.23M | Buy |
10,961
+561
| +5% | +$62.8K | 0.09% | 175 |
|
2020
Q1 | $805K | Buy |
10,400
+600
| +6% | +$46.4K | 0.08% | 183 |
|
2019
Q4 | $932K | Hold |
9,800
| – | – | 0.08% | 178 |
|
2019
Q3 | $747K | Hold |
9,800
| – | – | 0.07% | 180 |
|
2019
Q2 | $860K | Buy |
9,800
+4,800
| +96% | +$421K | 0.08% | 173 |
|
2019
Q1 | $453K | Hold |
5,000
| – | – | 0.05% | 225 |
|
2018
Q4 | $359K | Sell |
5,000
-1,800
| -26% | -$129K | 0.04% | 240 |
|
2018
Q3 | $652K | Hold |
6,800
| – | – | 0.06% | 201 |
|
2018
Q2 | $647K | Buy |
+6,800
| New | +$647K | 0.06% | 195 |
|